IL6 and depressive symptom measurement: Based on findings from previous studies, we hypothesized that Asp358Ala would be associated with elevated serum IL-6 but decreased serum CRP levels at age 9 years, and with decreased risks of depression and psychosis at age 18 years in the ALSPAC birth cohort.